Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: Demographic, Disease, and Treatment Characteristics of Primary Tracheal Cancers.
Journal: Annals of surgical oncology
Published: September 12, 2025
Correction: Treatment outcomes and comparative survival analysis of intraductal carcinoma of the prostate.
Journal: International urology and nephrology
Published: September 04, 2025
Treatment outcomes and comparative survival analysis of intraductal carcinoma of the prostate.
Journal: International urology and nephrology
Published: November 05, 2024
Demographic, Disease, and Treatment Characteristics of Primary Tracheal Cancers.
Journal: Annals of surgical oncology
Published: May 31, 2024
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.
Journal: World journal of gastrointestinal oncology
Published: May 21, 2023
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.
Journal: Cancers
Published: October 14, 2021
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 22, 2021
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy.
Journal: Journal for immunotherapy of cancer
Published: September 02, 2020
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study.
Journal: Journal for immunotherapy of cancer
Published: July 06, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026